June 2016 CAC Update

There was only 1 proposed LCD policy discussed at this meeting that may have some relevance to Rheumatologists:

DL35062 Biomarkers Overview 
Click the link for more infomation on this proposed LCD policy.

Other topics of interest: 

• Germ line testing for DMD, Dystrophin, in Duchene/Becker Muscular Dystrophy is not covered
• Cytochrome P 450 testing:
  •     CYP2C19 (Plavix metabolism) is only covered with Acute coronary syndrome with planned PCI
  •     CYP2D6 (tricyclic antidepressants metabolism) can be ordered only if Amitriptyline or Nortriptyline are prescribed to treat depression.